NY Study: Risk Factors for Mortality in Patients with COVID-19 in New York City
In this study of over 6000 hospitalized patients with COVID-19 in the New York City, hydroxychloroquine use was associated with decreased mortality.
In this study of over 6000 hospitalized patients with COVID-19 in the New York City, hydroxychloroquine use was associated with decreased mortality.
The UK medicines agency has given the green light to resume a clinical trial of hydroxychloroquine to prevent Covid-19.
The drastic failure to report honestly on HCQ goes far beyond incompetence: it is abetting the unspeakable forces who do not want people to be reliably cured during this pandemic until they can realize pandemic-level profits.
Hydroxychloroquine use was associated with decreased mortality.